References
- SambharaDArefAAGlaucoma management: relative value and place in therapy of available drug treatmentsTher Adv Chronic Dis201451304324381726
- BucoloCPlataniaCBReibaldiMControversies in glaucoma: current medical treatment and drug developmentCurr Pharm Des201521324673468126350532
- DeokuleSSadiqSShahSChronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptomsOphthalmic Physiol Opt200424191514687196
- ReardonGKotakSSchwartzGFObjective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic reviewPatient Prefer Adherence2011544146322003282
- NordmannJPBaudouinCRenardJPMeasurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a surveyClin Ophthalmol2010473173920689790
- FriedmanDSQuigleyHAGelbLUsing pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)Invest Ophthalmol Vis Sci200748115052505717962457
- KonstasAGMaskalerisGGratsonidisSSardelliCCompliance and viewpoint of glaucoma patients in GreeceEye200014Pt 575275611116698
- SleathBBlalockSCovertDThe relationship between glaucoma medication adherence, eye drop technique, and visual field defect severityOphthalmology2011118122398240221856009
- PatelSCSpaethGLCompliance in patients prescribed eyedrops for glaucomaOphthalmic Surg19952632332367651690
- OlthoffCMSchoutenJSvan de BorneBWWebersCANoncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based reviewOphthalmology2005112695396115885795
- SchwartzGFHollanderDAWilliamsJMEvaluation of eye drop administration technique in patients with glaucoma or ocular hypertensionCurr Med Res Opin201329111515152224006861
- DreerLEGirkinCACampbellLWoodAGaoLOwsleyCGlaucoma medication adherence among African Americans: program developmentOptom Vis Sci201390888389723873033
- BaudouinCRenardJPNordmannJPPrevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertensionEur J Ophthalmol20132314754
- Garcia-FeijooJSampaolesiJRA multicenter evaluation of ocular surface disease prevalence in patients with glaucomaClin Ophthalmol2012644144622536034
- DayDGSharpeEDAtkinsonMJStewartJAStewartWCThe clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patientsEye200620558359015933751
- StewartWCKonstasAGPfeifferNPatient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatmentJ Ocul Pharmacol Ther200420646146915684806
- HigginbothamEJConsiderations in glaucoma therapy: fixed combinations versus their component medicationsClin Ophthalmol201041920169043
- LewisRAGrossRLSallKNSchiffmanRMLiuCCBatoosinghALfor the Ganfort Investigators Group IIThe safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionJ Glaucoma201019642442619855289
- LingZZhangMHuYSafety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertensionChin Med J (Engl)2014127590591024571886
- LouHWangHZongYChengJWWeiRLEfficacy and tolerability of prostaglandin-timolol fixed combinations: an updated systematic review and meta-analysisCurr Med Res Opin20153161139114725867658
- FangYLingZSunXFixed-combination treatments for intraocular hypertension in Chinese patients – focus on bimatoprost-timololDrug Des Devel Ther2015926172625
- KerrNMPatelHYChewSSAliNQEadyEKDanesh-MeyerHVPatient satisfaction with topical ocular hypotensivesClin Experiment Ophthalmol2013411273522594958
- BullerAJMorganLHHerculesBLPatients prefer once-daily glaucoma dropsGraefes Arch Clin Exp Ophthalmol2007245229329416636837